BENATTI, BEATRICE
 Distribuzione geografica
Continente #
EU - Europa 7.716
NA - Nord America 6.948
AS - Asia 6.549
SA - Sud America 935
AF - Africa 194
OC - Oceania 119
Continente sconosciuto - Info sul continente non disponibili 6
Totale 22.467
Nazione #
US - Stati Uniti d'America 6.555
IT - Italia 2.666
GB - Regno Unito 1.881
SG - Singapore 1.807
CN - Cina 1.757
BR - Brasile 675
DE - Germania 591
HK - Hong Kong 545
VN - Vietnam 473
BD - Bangladesh 455
RU - Federazione Russa 441
IN - India 432
FR - Francia 403
SE - Svezia 397
CA - Canada 262
NL - Olanda 260
KR - Corea 223
TR - Turchia 214
ES - Italia 186
JP - Giappone 159
IE - Irlanda 151
FI - Finlandia 147
ID - Indonesia 130
AU - Australia 113
MX - Messico 80
PL - Polonia 78
AR - Argentina 74
CI - Costa d'Avorio 65
UA - Ucraina 62
BE - Belgio 60
GR - Grecia 58
CH - Svizzera 56
CO - Colombia 56
AT - Austria 43
IR - Iran 43
DK - Danimarca 41
TW - Taiwan 39
CL - Cile 38
ZA - Sudafrica 38
PH - Filippine 35
IL - Israele 32
IQ - Iraq 31
PE - Perù 30
PT - Portogallo 27
EC - Ecuador 26
MY - Malesia 25
RO - Romania 25
PK - Pakistan 24
MA - Marocco 22
UZ - Uzbekistan 21
LT - Lituania 19
EG - Egitto 17
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
CZ - Repubblica Ceca 15
EU - Europa 13
SK - Slovacchia (Repubblica Slovacca) 13
TN - Tunisia 13
VE - Venezuela 13
HU - Ungheria 11
KE - Kenya 11
NO - Norvegia 11
CR - Costa Rica 10
HR - Croazia 10
JM - Giamaica 10
LU - Lussemburgo 10
SI - Slovenia 10
TH - Thailandia 10
AZ - Azerbaigian 9
BO - Bolivia 9
BY - Bielorussia 8
RS - Serbia 8
BG - Bulgaria 7
HN - Honduras 7
PY - Paraguay 7
JO - Giordania 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
AL - Albania 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
LB - Libano 5
PR - Porto Rico 5
PS - Palestinian Territory 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
CY - Cipro 4
DZ - Algeria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
GH - Ghana 3
IS - Islanda 3
MT - Malta 3
NP - Nepal 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 22.436
Città #
Southend 1.593
Singapore 998
Ashburn 763
Milan 582
Chandler 492
Hong Kong 478
Dallas 386
San Jose 358
Beijing 257
Council Bluffs 232
Rome 226
Los Angeles 202
Fairfield 201
Hefei 191
Redwood City 186
New York 175
Boardman 161
Princeton 156
Seattle 156
Wilmington 151
Hanoi 149
Dublin 148
Santa Clara 141
Frankfurt am Main 136
Seoul 134
Bengaluru 129
Ho Chi Minh City 126
Houston 126
Ann Arbor 117
São Paulo 114
Munich 105
Lauterbourg 98
Woodbridge 93
Buffalo 91
Shanghai 81
Jakarta 79
Cambridge 78
Guangzhou 71
Istanbul 69
Tokyo 66
Abidjan 65
Ottawa 65
Moscow 64
Dearborn 62
Helsinki 62
Berlin 55
Naples 55
Des Moines 54
Nanjing 50
Phoenix 50
Toronto 43
London 42
Mountain View 42
Cangzhou 40
Florence 40
Chicago 38
Columbus 37
Melbourne 36
Redmond 36
Nuremberg 35
The Dalles 34
Warsaw 33
Madrid 32
Turin 32
Jinan 31
Mumbai 31
Amsterdam 30
Brussels 30
Chennai 29
Hangzhou 29
San Diego 29
Tianjin 29
Shenyang 27
Sydney 27
Trieste 27
Vienna 27
Buenos Aires 26
Atlanta 25
Paris 25
Washington 25
Bogotá 24
Genoa 24
Montreal 24
Athens 23
Fuzhou 23
Lappeenranta 23
Salvador 23
San Francisco 23
Norwalk 22
Palermo 22
Rio de Janeiro 22
Barcelona 20
Bologna 20
Chengdu 20
Da Nang 20
Pittsburgh 20
Turku 20
Falls Church 19
Haiphong 19
Orem 19
Totale 12.074
Nome #
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 1.185
Clinical characterization of Italian suicide attempters with bipolar disorder 977
Effetti dei sintomi sottosoglia nel disturbo di panico e nel disturbo d’ansia generalizzato : un’analisi trasversale 892
Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder 580
Suicidal ideation and suicidal attempts in patients with obsessive-compulsive tic-related disorder vs obsessive-compulsive disorder: results of a multicenter Italian study 531
Effectiveness, tolerability, and dropout rates of vortioxetine in comorbid depression: A naturalistic study 505
Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder : a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 472
Epigenetic modulation of BDNF gene in patients with major depressive disorder 466
Investigating duration of illness and duration of untreated illness in obsessive compulsive disorder reveals patients remain at length pharmacologically untreated 453
Past, present and future of transcranial magnetic stimulation (TMS) in the treatment of psychiatric disorders 406
Shared obsessive-compulsive disorder : an Italian case report 376
Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses 364
Early-onset obsessive-compulsive disorder: Sociodemographic and clinical characterization of a large outpatient cohort 318
Application of a Staging Model in Patients with Obsessive Compulsive Disorder : Cross-Sectional and Follow-up Results 274
Cannabis use and related clinical variables in patients with obsessive-compulsive disorder 272
Augmentative transcranial direct current stimulation (tDCS) in poor responder depressed patients : a follow-up study 260
Advances in problematic usage of the internet research - A narrative review by experts from the European network for problematic usage of the internet 250
Structural and metabolic differentiation between bipolar disorder with psychosis and substance induced psychosis : an integrated MRI/PET study 242
Human induced pluripotent stem cells technology in treatment resistant depression : novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms 239
Does initial use of benzodiazepines delay an adequate pharmacological treatment? A multicentre analysis in patients with psychotic and affective disorders 238
The role of gender in a large international OCD sample: A Report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) Network 237
A new tool to assess duration of untreated illness: Psychopathological Onset and Latency to Treatment Questionnaire (POLT-Q) = Un nuovo strumento per valutare la durata di malattia non trattata: il questionario sull’esordio psicopatologico e la latenza al trattamento (POLT-Q) 236
Transcranial Direct Current Stimulation (tDCS) in patients with Major Depressive Episode 234
Augmentative repetitive Transcranial Magnetic Stimulation (rTMS) in the acute treatment of poor responder depressed patients : a comparison study between high and low frequency stimulation 225
Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders : a naturalistic study 224
Climate Change Perception and Mental Health. Results from a Systematic Review of the Literature 223
Antidepressants in bipolar disorder : Analysis of correlates overall, and in BD-I and BD-II subsamples 222
Psychiatric comorbidity in bipolar disorder: which association prevail in different age groups 216
What Happened to Patients With Obsessive Compulsive Disorder During the COVID-19 Pandemic? A Multicentre Report From Tertiary Clinics in Northern Italy 214
Intensive Neurofeedback Protocol: An Alpha Training to Improve Sleep Quality and Stress Modulation in Health Care Professionals During the Covid-19 Pandemic. A Pilot Study 211
Access and latency to first antipsychotic treatment in Italian patients with schizophrenia and other schizophrenic spectrum disorders across different epochs 211
Polypharmacy as maintenance treatment in bipolar illness : A systematic review 210
Neuroimaging data in bipolar disorder : an updated view 209
Reduced duration of untreated illness over time in patients with schizophrenia spectrum, mood and anxiety disorders 206
Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients 203
Differences in latency to first pharmacological treatment duration of untreated illness in anxiety disorders : a study on patients with panic disorder, generalized anxiety disorder and obsessive-compulsive disorder 203
Differentiating multiple vs single lifetime suicide attempters with bipolar disorders: A retrospective study 202
Epigenetic modulation of BDNF gene : differences in DNA methylation between unipolar and bipolar patients 201
Criminal behaviors and substance use disorder in psychiatric patients 200
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS 200
Socio-demographic and clinical characterization of patients with Obsessive-Compulsive Tic-related Disorder (OCTD): an Italian multicenter study 197
Regulation of gene transcription in bipolar disorders : Role of DNA methylation in the relationship between prodynorphin and brain derived neurotrophic factor 197
Clinical characteristics and comorbidity associated with female gender in obsessive-compulsive disorder 197
Neuroimaging procedures and related acquisitions in bipolar disorder : state of the art 196
In Search for Biomarkers in Obsessive-Compulsive Disorder: New Evidence on Saliva as a Practical Source of DNA to Assess Epigenetic Regulation 195
Factors characterizing access and latency to first pharmacological treatment in Italian patients with schizophrenia, mood, and anxiety spectrum disorders 188
Italian patients with more recent onset of Major Depressive Disorder have a shorter duration of untreated illness 187
Duloxetine versus iv Citalopram in partial/non responder depressed patients : a randomized placebo-controlled study 185
Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder? 181
A case of treatment-resistant bipolar depression and comorbid OCD treated with deep brain stimulation of the medial forebrain bundle : 5 years follow-up results 179
A preliminary investigation of Cyberchondria and its correlates in a clinical sample of patients with obsessive–compulsive disorder, anxiety and depressive disorders attending a tertiary psychiatric clinic 178
A 6 month follow up study on response and relapse rates following an acute trial of repetitive Transcranial Magnetic Stimulation (rTMS) in patients with Major Depression 177
Brexpiprazole augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary retrospective observational study 175
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression 175
Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII 174
The Role of Lifestyle on Adherence to Treatment in a Sample of Patients with Unipolar and Bipolar Depression 171
Prevalence and disability of comorbid social phobia and obsessive-compulsive disorder in patients with panic disorder and generalized anxiety disorder 171
Mood stabilizers for patients with bipolar disorder : the state of the art 170
Assessing response, remission and treatment resistance in patients with Obsessive-Compulsive Disorder with and without Tic Disorders: Results from a multicenter study 170
Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review 170
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach 168
Childhood, adolescent and adult age at onset and related clinical correlates in obsessive–compulsive disorder : a report from the International College of Obsessive–Compulsive Spectrum Disorders (ICOCS) 168
Characterizing impulsivity profile in patients with obsessive-compulsive disorder 164
Efficacy, tolerability, compliance, and quality of life of patients with mood disorders switched from quetiapine immediate release to extended release 162
Lessons from a multicenter, international, large sample size analysis of patients with obsessive–compulsive disorders: an overview of the ICOCS Snapshot studies 160
Differences in duration of untreated illness, duration, and severity of illness among clinical phenotypes of obsessive-compulsive disorder 160
Parsing the phenotype of obsessive-compulsive tic disorder (OCTD): a multidisciplinary consensus 158
The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder : a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) 153
Repetitive Transcranial Magnetic Stimulation for the Treatment of Depression in a Real-World Setting: Findings from a Cohort Study 152
Gender impact on the outcome of rehabilitation programs in psychiatry: Brief report from a metropolitan residential rehabilitative service 151
Prevalence of suicide attempt and clinical characteristics of suicide attempters with obsessive-compulsive disorder: A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 150
Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort 149
Regulation of oxytocin receptor gene expression in obsessive-compulsive disorder: a possible role for the microbiota-host epigenetic axis 147
Clinical use of transcranial direct current stimulation in depressive disorders : the state of the art = Utilizzo clinico della stimolazione transcranica con corrente diretta nei disturbi dell’umore : lo stato dell’arte 146
Cigarette smoking in patients with obsessive compulsive disorder : a report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) 144
Il desiderio e l’ossessione del desiderio 140
Post-partum obsessive-compulsive disorder associated with 9q33.1 deletion 139
Obsessive-compulsive disorder in the elderly: A report from the International College of Obsessive-Compulsive Disorders (ICOCS) 138
Gender differences in relation to comorbidity patterns and abuse in bipolar disorders 137
Transcranial direct current stimulation in patients with treatment-resistant major depressive episode 136
Clinical features associated with increased severity of illness in tertiary clinic referred patients with obsessive compulsive disorder 134
GENDER DIFFERENCES IN GAMBLING DISORDER: RESULTS FROM AN ITALIAN MULTICENTRIC STUDY 133
Use of atypical antipsychotics as mono-poly therapy with mood stabilizers for the treatment of bipolar disorder an update 133
A possible role for G-quadruplexes formation and DNA methylation at IMOOD gene promoter in Obsessive Compulsive Disorder 131
Paroxetine in the treatment of panic disorder: a comparison between slow and standard up-titrations 131
Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine 130
Outcome predictors in patients with obsessive compulsive disorder: a prospective naturalistic study 129
First vs second wave of COVID-19 pandemic in patients with obsessive compulsive disorder: A multicentre report from tertiary clinics in Northern Italy 124
Effects of mindfulness-based interventions on symptoms and interoception in trauma-related disorders and exposure to traumatic events: Systematic review and meta-analysis 123
Partial response to antidepressant treatment: The role of nutraceutical compounds 121
Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project) 120
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports 119
Genetic and epigenetic architecture of Obsessive-Compulsive Disorder: in search of possible diagnostic and prognostic biomarkers 117
Tanscranial direct current stimulation in depression: a comparison between therapeutic effects obtained in hospitalized vs non-hospitalized patients 116
The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing : a case report 115
Obsessive–Compulsive Disorder as an Epiphenomenon of Comorbid Bipolar Disorder? An Updated Systematic Review 113
Selective alterations of endocannabinoid system genes expression in obsessive compulsive disorder 112
COVID-19 and psychiatric disorders among young people: a cross-sectional study 109
Prevalence of Selective Serotonin Reuptake Inhibitor-Related Apathy in Patients with Obsessive Compulsive Disorder 109
The use of transcranial magnetic stimulation (TMS) for Obsessive- compulsive disorder (OCD) 106
Totale 22.667
Categoria #
all - tutte 66.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021130 0 0 0 0 0 0 0 0 0 0 0 130
2021/20221.786 197 120 147 129 147 88 116 122 152 176 89 303
2022/20232.044 265 167 187 199 181 298 78 146 194 59 149 121
2023/20242.022 96 146 134 153 380 236 141 144 76 144 181 191
2024/20254.026 143 313 150 377 293 232 283 382 287 447 382 737
2025/20267.933 893 617 859 625 588 455 984 359 731 590 933 299
Totale 23.288